Childrens Specialty Group PLLC
Biotech · Private
Peptide inhibitor of complement C1q (PIC) for neonatal hypoxic ischemic encephalopathy
csgdocs.com →- Grants
- $841K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Peptide inhibition of complement-mediated hemolysis after xenotransfusion. | $149,930 | |
| Federal grant | Department of Health and Human Services · Phase I · Peptide inhibition of complement-mediated hemolysis after xenotransfusion. | $149,930 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of Peptide Inhibitor of Complement to treat neonatal asphyxial brain damage | $270,637 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of Peptide Inhibitor of Complement to treat neonatal asphyxial brain damage | $270,637 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3031 | Expedition Medicines | — | — |
| 3032 | HUMURINE TECHNOLOGIES, INC. | — | — |
| 3033 | PHENVOGEN, LLC | — | — |
| 3034 | Childrens Specialty Group PLLC | — | — |
| 3035 | Twenty First Century Therapeutics, Inc. | — | — |
| 3036 | Surface Oncology | — | — |
| 3037 | OPSIN BIOTHERAPEUTICS INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.